
Feature|Articles|August 4, 2026
Inside Pharma's Patent Battleground: The Policy Changes Reshaping Generic and Biosimilar Competition
Author(s)Ed Silverman
Recent changes at the U.S. Patent and Trademark Office are making it harder to challenge pharmaceutical patents, raising concerns that slower generic and biosimilar competition could undermine efforts to lower drug costs while strengthening protections for brand-name innovators.
Advertisement
Advertisement
A key Trump administration agency is drawing controversy over policies that might slow the process for bringing lower-cost medicines to market. Over the past year, the U.S. Patent & Trademark Office (PTO) has taken several steps that were billed as preserving patents from unnecessary legal challenges and strengthening the system for protecting innovation.
Related to this article

Four principles for getting AI agents past the pilot phase in regulated pharma manufacturing.

Regeneron's Livsayis (cemdisiran) gains FDA approval for adults with antibody-positive generalized myasthenia gravis, dosed four times a year.

J&J’s separations of Kenvue and DePuy Synthes test whether Innovative Medicine and MedTech create more value together than apart.

The month's biggest moves — from Pfizer and Blackstone's obesity co-funding agreement to Lilly's $3.5B Pennsylvania groundbreaking — answered in plain language.

White House withdraws Dr. Heidi Overton’s FDA commissioner nomination amid Senate GOP pushback, Pfizer and Verismo advance in vivo CAR-T manufacturing through new licensing deals, and Infinitus’s Ankit Jain discusses balancing workloads between humans and agentic AI.

The White House has withdrawn Dr. Heidi Overton’s nomination for FDA commissioner just a day before a Senate committee vote.

Gilead signs royalty-free licensing deals to broaden Ebola antiviral access, FDA approves Cosentyx for polymyalgia rheumatica and Wilserdly for ESR1-mutated breast cancer, and Infinitus’s Ankit Jain talks agentic AI’s role in pharma’s commercial model.
Advertisement
Advertisement

